These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 16517285

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. A novel mutation in FKBP12.6 binding region of the human cardiac ryanodine receptor gene (R2401H) in a Japanese patient with catecholaminergic polymorphic ventricular tachycardia.
    Aizawa Y, Ueda K, Komura S, Washizuka T, Chinushi M, Inagaki N, Matsumoto Y, Hayashi T, Takahashi M, Nakano N, Yasunami M, Kimura A, Hiraoka M, Aizawa Y.
    Int J Cardiol; 2005 Mar 18; 99(2):343-5. PubMed ID: 15749201
    [Abstract] [Full Text] [Related]

  • 4. Molecular genetics of exercise-induced polymorphic ventricular tachycardia: identification of three novel cardiac ryanodine receptor mutations and two common calsequestrin 2 amino-acid polymorphisms.
    Laitinen PJ, Swan H, Kontula K.
    Eur J Hum Genet; 2003 Nov 18; 11(11):888-91. PubMed ID: 14571276
    [Abstract] [Full Text] [Related]

  • 5. Unusual clinical presentation in a family with catecholaminergic polymorphic ventricular tachycardia due to a G14876A ryanodine receptor gene mutation.
    Allouis M, Probst V, Jaafar P, Schott JJ, Le Marec H.
    Am J Cardiol; 2005 Mar 01; 95(5):700-2. PubMed ID: 15721128
    [Abstract] [Full Text] [Related]

  • 6. Cardiac ryanodine receptor gene (hRyR2) mutation underlying catecholaminergic polymorphic ventricular tachycardia in a Chinese adolescent presenting with sudden cardiac arrest and cardiac syncope.
    Mok NS, Lam CW, Fong NC, Hui YW, Choi YC, Chan KY.
    Chin Med J (Engl); 2006 Dec 20; 119(24):2129-33. PubMed ID: 17199967
    [No Abstract] [Full Text] [Related]

  • 7. High prevalence of exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia mutation-positive family members diagnosed by cascade genetic screening.
    Haugaa KH, Leren IS, Berge KE, Bathen J, Loennechen JP, Anfinsen OG, Früh A, Edvardsen T, Kongsgård E, Leren TP, Amlie JP.
    Europace; 2010 Mar 20; 12(3):417-23. PubMed ID: 20106799
    [Abstract] [Full Text] [Related]

  • 8. Calcium channel antagonism reduces exercise-induced ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia patients with RyR2 mutations.
    Swan H, Laitinen P, Kontula K, Toivonen L.
    J Cardiovasc Electrophysiol; 2005 Feb 20; 16(2):162-6. PubMed ID: 15720454
    [Abstract] [Full Text] [Related]

  • 9. Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia.
    Hayashi M, Denjoy I, Extramiana F, Maltret A, Buisson NR, Lupoglazoff JM, Klug D, Hayashi M, Takatsuki S, Villain E, Kamblock J, Messali A, Guicheney P, Lunardi J, Leenhardt A.
    Circulation; 2009 May 12; 119(18):2426-34. PubMed ID: 19398665
    [Abstract] [Full Text] [Related]

  • 10. Identification of novel missense mutations of cardiac ryanodine receptor gene in exercise-induced sudden death at autopsy.
    Creighton W, Virmani R, Kutys R, Burke A.
    J Mol Diagn; 2006 Feb 12; 8(1):62-7. PubMed ID: 16436635
    [Abstract] [Full Text] [Related]

  • 11. Catecholaminergic polymorphic ventricular tachycardia.
    Liu N, Ruan Y, Priori SG.
    Prog Cardiovasc Dis; 2008 Feb 12; 51(1):23-30. PubMed ID: 18634915
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients.
    Postma AV, Denjoy I, Kamblock J, Alders M, Lupoglazoff JM, Vaksmann G, Dubosq-Bidot L, Sebillon P, Mannens MM, Guicheney P, Wilde AA.
    J Med Genet; 2005 Nov 12; 42(11):863-70. PubMed ID: 16272262
    [Abstract] [Full Text] [Related]

  • 14. Novel ryanodine receptor 2 mutation associated with a severe phenotype of catecholaminergic polymorphic ventricular tachycardia.
    LaPage MJ, Russell MW, Bradley DJ, Dick M.
    J Pediatr; 2012 Aug 12; 161(2):362-4. PubMed ID: 22608700
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ryanodine receptor (RyR2) mutations in sudden cardiac death: studies in extended pedigrees and phenotypic characterization in vitro.
    Marjamaa A, Laitinen-Forsblom P, Wronska A, Toivonen L, Kontula K, Swan H.
    Int J Cardiol; 2011 Mar 03; 147(2):246-52. PubMed ID: 19781797
    [Abstract] [Full Text] [Related]

  • 17. A novel mutation in the RYR2 gene leading to catecholaminergic polymorphic ventricular tachycardia and paroxysmal atrial fibrillation: dose-dependent arrhythmia-event suppression by β-blocker therapy.
    Kazemian P, Gollob MH, Pantano A, Oudit GY.
    Can J Cardiol; 2011 Mar 03; 27(6):870.e7-10. PubMed ID: 21652165
    [Abstract] [Full Text] [Related]

  • 18. A novel variant in RyR2 causes familiar catecholaminergic polymorphic ventricular tachycardia.
    Bosch C, Campuzano O, Sarquella-Brugada G, Cesar S, Perez-Serra A, Coll M, Mademont I, Mates J, Del Olmo B, Iglesias A, Brugada J, Petersen V, Brugada R.
    Forensic Sci Int; 2017 Jan 03; 270():173-177. PubMed ID: 27988446
    [Abstract] [Full Text] [Related]

  • 19. Catecholaminergic polymorphic ventricular tachycardia found in an adolescent after a methylenedioxymethamphetamine and marijuana-induced cardiac arrest.
    Diffley M, Armenian P, Gerona R, Reinhartz O, Avasarala K.
    Crit Care Med; 2012 Jul 03; 40(7):2223-6. PubMed ID: 22584762
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.